Family Medicine · Newport, TN
NPI
1053396432
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
407 4th St
Newport, TN, 37821
Phone (423) 623-4240
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
5,665 services
Medicare patients, 2024
321
Average age 72
Drug cost, 2024
$2.6M
26,705 prescriptions
Company payments, 2025
$1,487
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael T Hood was code 99214 (office e&m - established), 565 times for 215 patients. In total Michael T Hood billed 5,665 services in 172 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 565 | 215 | $77.81 | $44K |
| 36415 Venipuncture Blood Collection | Office | 429 | 201 | $7.89 | $3,384 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 384 | 57 | $0.08 | $29.47 |
| 80053 Clinical Chemistry | Office | 313 | 172 | $9.92 | $3,106 |
| 99213 Office E&M - Established | Office | 299 | 165 | $48.05 | $14K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 221 | 23 | $47.28 | $10K |
| 80061 Clinical Chemistry | Office | 217 | 140 | $12.64 | $2,742 |
| 96372 Injection Administration | Office | 173 | 75 | $9.10 | $1,574 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 173 | 35 | $0.29 | $50.01 |
| 85025 Blood Count | Office | 153 | 98 | $7.31 | $1,119 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 97 | $11.94 | $1,790 |
| 84443 Clinical Chemistry | Office | 119 | 81 | $16.18 | $1,926 |
| 83036 Blood Count | Office | 118 | 76 | $8.88 | $1,047 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 117 | 117 | $126.46 | $15K |
| 81001 Clinical Chemistry | Office | 101 | 69 | $3.08 | $311 |
By year: 2022 $129K for 9,211 services; 2023 $172K for 7,062 services; 2024 $155K for 5,665 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 429 | 201 | $7.89 | $3,384 |
| 80053 Clinical Chemistry | 313 | 172 | $9.92 | $3,106 |
| 80061 Clinical Chemistry | 217 | 140 | $12.64 | $2,742 |
| 85025 Blood Count | 153 | 98 | $7.31 | $1,119 |
| 84443 Clinical Chemistry | 119 | 81 | $16.18 | $1,926 |
| 83036 Blood Count | 118 | 76 | $8.88 | $1,047 |
| 81001 Clinical Chemistry | 101 | 69 | $3.08 | $311 |
| 82570 Clinical Chemistry | 61 | 42 | $4.58 | $280 |
| 82043 Clinical Chemistry | 60 | 42 | $5.19 | $311 |
| 86140 Clinical Chemistry | 58 | 47 | $4.82 | $279 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael T Hood prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,027 prescriptions and refills. In total Michael T Hood wrote 26,705 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,027 | 1,027 | 182 | $24K |
| Atorvastatin Calcium Generic | 894 | 2,198 | 236 | $6,432 |
| Lisinopril Generic | 879 | 2,183 | 240 | $5,043 |
| Levothyroxine Sodium Generic | 770 | 1,793 | 181 | $5,167 |
| Rosuvastatin Calcium Generic | 744 | 1,951 | 205 | $7,742 |
| Gabapentin Generic | 627 | 669 | 108 | $7,042 |
| Amlodipine Besylate Generic | 602 | 1,535 | 178 | $2,786 |
| Montelukast Sodium Generic | 520 | 1,124 | 145 | $3,694 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 505 | 579 | 152 | $12K |
| Metoprolol Succinate Generic | 489 | 1,140 | 131 | $4,838 |
| Furosemide Generic | 481 | 931 | 125 | $1,933 |
| Omeprazole Generic | 454 | 993 | 119 | $6,275 |
| Alprazolam Generic | 435 | 435 | 56 | $1,456 |
| Oxycodone Hcl Generic | 430 | 430 | 45 | $7,074 |
| Hydroxychloroquine Sulfate Generic | 394 | 763 | 103 | $13K |
Brand drugs: 3,547 claims; generic drugs: 22,971 claims; opioid claims: 1,977.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael T Hood $1,487 ($1,487 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novo Nordisk Inc with $384.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $384 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $153 |
| Abbvie Inc. ABBV | 10 | $135 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $105 |
| Viatris Specialty LLC | 3 | $74.79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $73.06 |
| Pfizer Inc. PFE | 4 | $69.23 |
| Corcept Therapeutics CORT | 3 | $54.87 |
| GlaxoSmithKline, LLC. GSK | 3 | $50.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.